Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 284
Selected: 0
NCT IDTitle
NCT01787383A Simultaneous Treatment Regimen Compared to a Sequential Treatment Regimen With Ingenol Mebutate Gel 0.015% and 0.05% of Two Areas With Actinic Keratosis on Face/Scalp and Trunk/Extremities
NCT03402828Body PSOriasis: Long-term Relapse CONTROL
NCT04361136Clinical Trial to Evaluate Light-induced Skin Reactions After Application of Delgocitinib Cream
NCT01866163LEO 90100 Compared to Vehicle in Subjects With Psoriasis Vulgaris
NCT04853992Trial to Assess the Efficacy and Safety of LEO 152020 in Adult Patients With Cholinergic Urticaria
NCT00845481A Plaque Test Comparing the Anti-psoriatic Effect of Marketed Products for Topical Use for Psoriasis Vulgaris
NCT04674826A Trial to Compare the Pharmacokinetics of Tralokinumab in Healthy Subjects
NCT05919082A Study to Investigate Efficacy and Safety With LEO 90100 Compared With Daivobet® Ointment in Adult Chinese Subjects With Stable Plaque Psoriasis
NCT03363854Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3
NCT00875277A Psoriasis Plaque Test With LEO 29102 Cream and Its Combination Products
NCT04922021An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.
NCT00475605A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
NCT01536886LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris
NCT03995550Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics After Single and Multiple Doses of LEO 142397 in Healthy People, Including Japanese
NCT05050279A Trial to Evaluate the Effect of Delgocitinib on the Heart Rhythm of Healthy People
NCT03806790Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis Vulgaris
NCT02377999Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts
NCT01466478An Exploratory Psoriasis Plaque Test Study With LEO 29102 Plus Calcipotriol, Ointment, in Psoriasis Vulgaris
NCT01850849Safety, Tolerability and Pharmacokinetics in AD Subjects and Healthy Subjects of Cutaneous Application of LEO 39652 Cream
NCT02126371LP0058-1005 - A Open-Label, Four-Way Crossover and Food-Effect Study of LEO 32731 in Healthy Subjects
NCT01229098Effect of LEO 80185 Gel on the HPA Axis and Calcium Metabolism in Subjects With Extensive Psoriasis Vulgaris
NCT00216892Efficacy and Safety of Calcipotriol Cream and (Calcipotriol + Betamethasone Dipropionate) Ointment in Psoriasis Vulgaris
NCT05098821Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation
NCT01387711PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Histology
NCT02132936LEO 90100 Aerosol Foam Compared to Calcipotriol Plus Betamethasone Dipropionate Gel in Subjects With Psoriasis Vulgaris
NCT03358914The PsoTeenQOL - Preliminary Reliability and Validity
NCT03526861Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
NCT03476746Dermatopharmacokinetic Trial of LEO 90100 Foam
NCT02627989An Observational Study Investigating the Treatment Satisfaction of Atopic Dermatitis Patients Who Have Switched to Ointment (W/O Emulsion) Formulation of Very Strong Class Topical Corticosteroids
NCT02935582PSOREAL - Managing PSOriasis in the REAL World
NCT04883333A Single and Multiple Ascending-dose Trial of LEO 153339 in Healthy Adults
NCT02650505A Clinical Study to Evaluate the Sensitizing Potential of LEO 43204 Gel
NCT01320774Efficacy, Tolerability and Handling of Daivobet® Gel in Patients With Psoriasis Vulgaris
NCT03192280Skin IaM: An Exploratory Clinical Trial to Evaluate Changes in Skin Appearance, Colour, and/or Texture Following the Induction of a Local Inflammatory Skin Response
NCT02533973Long-term Treatment of Scalp Psoriasis With Xamiol® Gel in a Large Adult Chinese Population
NCT02602470Preferences & Treatment Satisfaction Drivers in Rosacea Patients
NCT02580773Therapeutic Anticoagulation Strategy for Acute Chest Syndrome
NCT02406014Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp
NCT01025635Safety and Efficacy of Azelaic Acid Foam, 15% in Papulopustular Rosacea
NCT01195831Efficacy and Safety of Xamiol® Gel Compared to Calcipotriol Scalp Solution in Patients With Scalp Psoriasis
NCT01761019A Study to Determine the Efficacy of Taclonex Topical Suspension as a Supplement to Non-biologic Systemic Therapy
NCT01722812Cromoglicate in Psoriasis
NCT04872101Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema (DELTA 2)
NCT03683719Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema
NCT02695940Trial Twice Daily Application of LEO 124249 Ointment 30 mg/g in Treatment of Mild to Moderate Inverse Psoriasis
NCT02361216Efficacy and Safety of Ingenol Mebutate Gel for Actinic Keratosis Applied on Large Area on Face, Scalp or Chest
NCT01707043Patient Preference of Taclonex Ointment to Taclonex Scalp Suspension in Adult Subjects With Psoriasis Vulgaris
NCT00704262Effect of Calcipotriol Plus Hydrocortisone Ointment on the Adrenal Hormone Balance and Calcium Metabolism in Patients With Psoriasis Vulgaris on the Face and Skin Folds
NCT02251652Safety and Efficacy of Ingenol Mebutate 0.05% Gel When Used After Cryotherapy in the Hypertrophic Actinic Keratoses
NCT05099133A Trial to Evaluate Pharmacokinetics, Immunogenicity, Safety, and Tolerability of LEO 138559 in Healthy Japanese Subjects